TY - CHAP
T1 - Thyroid incidentalomas
AU - Delivanis, Danae A.
AU - Castro, M. Regina
PY - 2018/1/1
Y1 - 2018/1/1
N2 -
Thyroid incidentalomas are nonpalpable, asymptomatic thyroid nodules that are discovered on an imaging study performed to evaluate other structures or during an operation unrelated to the thyroid gland. Thyroid incidentalomas are most commonly detected on ultrasound (US) performed for evaluation of extra-thyroidal structures, followed in frequency by computed tomography (CT), magnetic resonance imaging (MRI), and
18
fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography [PET] (
18
FDG-PET). Clinically unrecognized thyroid nodules are common and can be found in up to 50–60% of patients at autopsy. Increased use of imaging modalities of better quality in the modern era has resulted in an increased detection of incidental thyroid nodules. Their clinical importance is primarily related to the need to exclude thyroid cancer. The risk of malignancy in these nonpalpable nodules is similar to that of palpable nodules. As result, a thorough sonographic evaluation of the thyroid gland should be performed in the majority of patients with a thyroid incidentaloma. If a thyroid nodule is confirmed, then it should be evaluated in the same fashion as a clinical apparent thyroid nodule. As with most thyroid nodules, the majority will prove to be benign. However, as more studies come into light, we come to realize that the majority of incidental thyroid nodules that harbor cancerous cells are small indolent papillary carcinomas that do not result in increased mortality, and in such cases, a less aggressive and cost-effective approach is advised.
AB -
Thyroid incidentalomas are nonpalpable, asymptomatic thyroid nodules that are discovered on an imaging study performed to evaluate other structures or during an operation unrelated to the thyroid gland. Thyroid incidentalomas are most commonly detected on ultrasound (US) performed for evaluation of extra-thyroidal structures, followed in frequency by computed tomography (CT), magnetic resonance imaging (MRI), and
18
fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography [PET] (
18
FDG-PET). Clinically unrecognized thyroid nodules are common and can be found in up to 50–60% of patients at autopsy. Increased use of imaging modalities of better quality in the modern era has resulted in an increased detection of incidental thyroid nodules. Their clinical importance is primarily related to the need to exclude thyroid cancer. The risk of malignancy in these nonpalpable nodules is similar to that of palpable nodules. As result, a thorough sonographic evaluation of the thyroid gland should be performed in the majority of patients with a thyroid incidentaloma. If a thyroid nodule is confirmed, then it should be evaluated in the same fashion as a clinical apparent thyroid nodule. As with most thyroid nodules, the majority will prove to be benign. However, as more studies come into light, we come to realize that the majority of incidental thyroid nodules that harbor cancerous cells are small indolent papillary carcinomas that do not result in increased mortality, and in such cases, a less aggressive and cost-effective approach is advised.
KW - fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography [PET] ( FDG-PET)
KW - Computed tomography (CT)
KW - Fine-needle aspiration (FNA)
KW - Imaging studies
KW - Incidentalomas
KW - Magnetic resonance imaging (MRI)
KW - Mortality
KW - Thyroid cancer
KW - Thyroid nodule
KW - Thyroid ultrasound (US)
UR - http://www.scopus.com/inward/record.url?scp=85064873121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064873121&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-59474-3_11
DO - 10.1007/978-3-319-59474-3_11
M3 - Chapter
AN - SCOPUS:85064873121
T3 - Contemporary Endocrinology
SP - 153
EP - 167
BT - Contemporary Endocrinology
PB - Humana Press Inc.
ER -